Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2006-09-06

Original market date: See footnote 1

1995-12-31

Product name:

TYPHIM VI

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02130955

Product Monograph/Veterinary Labelling:

Date: 2021-06-15 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

SANOFI PASTEUR LIMITED
1755 Steeles Avenue West
Toronto
Ontario
Canada  M2R 3T4

Class: 

Human

Dosage form(s):

Solution

Route(s) of administration:

Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Schedule D  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

80:12.00   VACCINES

Anatomical Therapeutic Chemical (ATC): See footnote 4

J07AP03  TYPHOID, PURIFIED POLYSACCHARIDE ANTIGEN

Active ingredient group (AIG) number:See footnote 5

0144342002

List of active ingredient(s)
Active ingredient(s) Strength
SALMONELLA TYPHI VI CAPSULAR POLYSACCHARIDE VACCINE 25 MCG / 0.5 ML

Application information

Related information

Contact us

Version 3.9.0
Date modified: